# Tercica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tercica

- Industry: Biotechnology
- Headquarters: Brisbane, US
- Website: www.tercica.com
- Total disclosed funding: $44M
- Latest round: Series B (Jul 17, 2003)
- Investors on record: 5

## About

Tercica Inc was founded in 2000. It is a biotechnology company, engages in the development and commercialization of therapeutics for the treatment of endocrine and metabolic diseases.

## Funding rounds

- Series B, Jul 17, 2003, $44M — Care Capital, Prospect Venture Partners, RHO, MPM BioImpact, MedImmune Ventures

## Investors

- Care Capital (https://capitalatlas.ai/funds/care-capital) — Series B
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series B
- RHO (https://capitalatlas.ai/funds/rho) — Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series B
- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series B